Evidence map›Paper›PMID 27366048›Full record

ArticleAnnals of gastroenterology

Prospective small bowel mucosal assessment immediately after chemoradiotherapy of unresectable locally advanced pancreatic cancer using capsule endoscopy: a case series.

Takeshi Yamashina, Ryoji Takada, Noriya Uedo, Tomofumi Akasaka, Noboru Hanaoka, Yoji Takeuchi, Koji Higashino, Tatsuya Ioka, Ryu Ishihara, Teruki Teshima and 2 more

Open access · greenAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Annals of gastroenterology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 5 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Takeshi YamashinaGastrointestinal Oncology (Takeshi Yamashina, Noriya Uedo, Tomofumi Akasaka, Noboru Hanaoka, Yoji Takeuchi, Koji Higashino, Ruy Ishihara, Hiroyasu Iishi), Osaka, Japan; Department of Gastroenterology and Hepatology, Osaka Red Cross Hospital (Takeshi Yamashina), Osaka, Japan.
Ryoji TakadaDepartment of Pancreatic Oncology (Ryoji Takeda), Osaka, Japan.
Noriya UedoGastrointestinal Oncology (Takeshi Yamashina, Noriya Uedo, Tomofumi Akasaka, Noboru Hanaoka, Yoji Takeuchi, Koji Higashino, Ruy Ishihara, Hiroyasu Iishi), Osaka, Japan.
Tomofumi AkasakaGastrointestinal Oncology (Takeshi Yamashina, Noriya Uedo, Tomofumi Akasaka, Noboru Hanaoka, Yoji Takeuchi, Koji Higashino, Ruy Ishihara, Hiroyasu Iishi), Osaka, Japan.
Noboru HanaokaGastrointestinal Oncology (Takeshi Yamashina, Noriya Uedo, Tomofumi Akasaka, Noboru Hanaoka, Yoji Takeuchi, Koji Higashino, Ruy Ishihara, Hiroyasu Iishi), Osaka, Japan.
Yoji TakeuchiGastrointestinal Oncology (Takeshi Yamashina, Noriya Uedo, Tomofumi Akasaka, Noboru Hanaoka, Yoji Takeuchi, Koji Higashino, Ruy Ishihara, Hiroyasu Iishi), Osaka, Japan.
Koji HigashinoGastrointestinal Oncology (Takeshi Yamashina, Noriya Uedo, Tomofumi Akasaka, Noboru Hanaoka, Yoji Takeuchi, Koji Higashino, Ruy Ishihara, Hiroyasu Iishi), Osaka, Japan.
Tatsuya IokaDepartment of Cancer Survey (Tatsuya Ioka), Osaka, Japan.
Ryu IshiharaGastrointestinal Oncology (Takeshi Yamashina, Noriya Uedo, Tomofumi Akasaka, Noboru Hanaoka, Yoji Takeuchi, Koji Higashino, Ruy Ishihara, Hiroyasu Iishi), Osaka, Japan.
Teruki TeshimaDepartment of Radiation Oncology (Teruki Teshima, Kinji Nishiyama), Osaka Medical Center for Cancer and Cardiovascular Disease, Osaka, Japan.
Kinji NishiyamaDepartment of Radiation Oncology (Teruki Teshima, Kinji Nishiyama), Osaka Medical Center for Cancer and Cardiovascular Disease, Osaka, Japan.
Hiroyasu IishiGastrointestinal Oncology (Takeshi Yamashina, Noriya Uedo, Tomofumi Akasaka, Noboru Hanaoka, Yoji Takeuchi, Koji Higashino, Ruy Ishihara, Hiroyasu Iishi), Osaka, Japan.
Osaka International Cancer Institute · JPTakatsuki Red Cross Hospital · JPTakeda (Japan) · JPTaoka Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this case series, three consecutive patients with unresectable locally advanced pancreatic cancer (ULAPC) underwent capsule endoscopy (CE) before and after chemoradiotherapy (CRT) to evaluate duodenal and jejunal mucosa, and to examine the relationship between CE findings and dose distribution. CE after CRT showed duodenitis and proximal jejunitis in all three patients. The most inflamed region was the third part of the duodenum, and in dose distribution, this was the closest region to the center of irradiation. This case series shows that CE can safely diagnose acute duodenitis and proximal jejunitis caused by CRT for ULAPC, and that dose distribution is possible to predict the degree of duodenal and jejunal mucosal injuries.

Indexed as

capsule endoscopypancreatic cancerRadiation enteritis

Identifiers

PMID27366048
PMCPMC4923833
OpenAlexW2465214325

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.